Increased incidence of infection in verapamil-treated kidney transplant recipients

Transplant Proc. 2000 May;32(3):551-3. doi: 10.1016/s0041-1345(00)00886-1.

Authors

G Nanni¹, N Panocchia, R Tacchino, M Foco, E Piccioni, M Castagneto

Affiliation

¹ Transplant Unit, Department of Surgery, Catholic University, Roma, Italy.

PMID: 10812109
DOI: 10.1016/s0041-1345(00)00886-1

No abstract available

Publication types

Clinical Trial
Comparative Study

MeSH terms

Antilymphocyte Serum / adverse effects
Antilymphocyte Serum / therapeutic use
Calcium Channel Blockers / adverse effects*
Calcium Channel Blockers / therapeutic use
Graft Rejection / epidemiology
Graft Rejection / microbiology
Humans
Immunosuppressive Agents / adverse effects*
Immunosuppressive Agents / therapeutic use
Incidence
Infections / chemically induced*
Kidney Transplantation*
Verapamil / adverse effects*
Verapamil / therapeutic use

Substances

Antilymphocyte Serum
Calcium Channel Blockers
Immunosuppressive Agents
Verapamil